VANGUARD GROUP INC - AVALO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 76 filers reported holding AVALO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,535,000
-37.4%
3,070,553
-9.3%
0.00%–
Q1 2022$2,453,000
-57.3%
3,384,194
+0.1%
0.00%–
Q4 2021$5,744,000
-21.3%
3,379,303
+1.0%
0.00%–
Q3 2021$7,297,000–3,347,276–0.00%–
 Download
Other shareholders

There were no reported owners of AVALO THERAPEUTICS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of AVALO THERAPEUTICS INC shareholders